Strategic Partners A/S (CPH:STRAP)
640.00
0.00 (0.00%)
Jul 17, 2026, 11:47 AM CET
Strategic Partners Market Cap
Strategic Partners has a market cap or net worth of 26.7 million as of July 20, 2026. Its market cap has decreased by -44.59% in one year.
Market Cap
26.70M
Enterprise Value
10.77M
Revenue
309.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
640.00
ChartMarket Cap Chart
Since November 21, 2017, Strategic Partners's market cap has decreased from 1.59B to 26.70M, a decrease of -98.33%. That is a compound annual growth rate of -37.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 26.70M | -8.31% |
| Dec 30, 2025 | 29.11M | -15.40% |
| Dec 30, 2024 | 34.42M | -26.72% |
| Dec 29, 2023 | 46.96M | 51.14% |
| Dec 30, 2022 | 31.07M | -94.82% |
| Dec 30, 2021 | 599.78M | -74.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.46T |
| Genmab | 114.74B |
| Coloplast | 95.20B |
| Demant | 58.59B |
| Gubra | 5.59B |
| BioPorto | 559.47M |
| Pharma Equity Group | 105.57M |
| ViroGates | 88.18M |